期刊文献+

应用覆膜支架TIPS治疗不同类型慢性门静脉血栓术后肝性脑病发生探讨 被引量:11

A preliminary study on the occurrence of hepatic encephalopathy after TIPS using covered stent for different types of chronic portal vein thrombosis
下载PDF
导出
摘要 目的通过建立慢性门静脉血栓解剖分型指导临床TIPS操作,探讨分析不同类型门静脉血栓术后肝性脑病(HE)的发生与TIPS术式选择的关系。方法 2010年6月—2013年6月收治慢性门静脉血栓患者73例,行Fluency覆膜支架TIPS治疗。根据门静脉系统血栓不同部位,建立门静脉系统血栓解剖分型,评估TIPS手术前后门静脉压力变化、不同类型血栓患者接受TIPS治疗后15 d和3、6个月出现HE状况及病例数,并进行同一时间组间和不同时间变化对比。结果 TIPS治疗中Ⅰ型患者的分流前、后的门静脉压力分别为(42.7±9.6)和(35.0±6.7)cm H2O,差异有统计学意义(P<0.01);Ⅱ型患者分别为(39.8±5.5)和(31.0±5.7)cm H2O,差异有统计学意义(t=17.2,P<0.01);Ⅲ型患者TIPS分别为(43.2±5.8)和(32.4±5.0)cm H2O,差异有统计学意义(t=25.0,P<0.01);Ⅳ型患者分别为(43.0±3.7)和(36.6±6.6)cm H2O,差异有统计学意义(t=4.26,P<0.01)。术后15 d时发生轻微HE(MHE)的前三者为Ⅳ、Ⅰ和Ⅲb型,发生Ⅰ期HE前三者为Ⅱa、Ⅲb和Ⅰ型,发生Ⅱ期HE的前三者为Ⅱb、Ⅲb和Ⅰ型;术后3个月时发生MHE的前三者为Ⅲa、Ⅱa和Ⅱc型,发生Ⅰ期HE的前三者为Ⅲa、Ⅱb和Ⅳ型,发生Ⅱ期HE的前三者为Ⅱa、Ⅱb和Ⅲb型;术后6个月时发生MHE的前三者为Ⅱa、Ⅱc和Ⅲb型,发生I期HE的前三者为Ⅱb、Ⅰ和Ⅲb型,发生Ⅱ期HE的前三者为Ⅱb、Ⅲb和Ⅰ型;且Ⅱb、Ⅲb和Ⅰ型TIPS术后HE持续时间较长。结论建立合理的慢性门静脉系统血栓解剖分型可以有效的指导临床TIPS的应用,术后HE在单纯门静脉主干和单纯肠系膜上静脉血栓中的发生概率较高。 Objective To establish an anatomical classification of chronic portal vein thrombosis (PVT) in order to guide the transjugular intrahepatic portasystemic shunt (TIPS) manipulation, and to analyze the correlation between anatomical classification of PVT and the occurrence of hepatic encephalopathy (HE) after TIPS. Methods During the period from June 2010 to June 2013 at authors’ hospital, TIPS with fluency covered stent was carried out in a total of 73 patients with chronic portal vein thrombosis. Based on the location of portal vein thrombosis, the anatomical classification of portal vein thrombosis (PVT-type) was initially established. The changes in portal vein pressure after TIPS were evaluated. The occurrence of HE at 15 days and at 3 and 6 months after TIPS in patients with different PVT-type was statistically analyzed. As the understanding of 0-phase minimal hepatic encephalopathy (MHE) was deepened, the authors added a subdivision to the 0-phase, including normal cognitive function state and minimal hepatic encephalopathy (MHE) into West - Haven grading to further precisely assess the hepatic encephalopathy. Using&amp;nbsp;paired samples t-test, the changes of portal vein pressure after TIPS were evaluated. The grading of hepatic encephalopathy and the number of occurrence after TIPS were particularly recorded, the results were compared between groups at the same time and between the types at different times. Results The preoperative and postoperative portal vein pressure in type Ⅰ patients receiving TIPS therapy was (42.7 ± 9.6) and (35.0 ± 6.7) cm H2O respectively, the difference was statistically significant (t = 7.61, P 〈0.01);in typeⅡpatients it was(39.8 ± 5.5) and(31.0 ± 5.7) cm H2O respectively(t=17.2, P〈0.01);in type Ⅲpatients it was (43.2 ± 5.8) and (32.4 ± 5.0) cm H2O respectively (t = 25.0, P 〈 0.01); and in type Ⅳpatients it was (43.0 ± 3.7) and (36.6 ± 6.6) cm H2O respectively (t = 4.26, P 〈0.01). The occurrence of HE 15 days after TIPS was mainly seen in patients with type Ⅳ , Ⅰ and Ⅲb. Phase Ⅰ hepatic encephalopathy mainly occurred in patients with PVT-type Ⅱa, Ⅲb and type Ⅰ. Phase Ⅱ hepatic encephalopathy occurred mainly in patients with PVT-type Ⅱb, Ⅲb and type Ⅰ. Three months after TIPS, the occurrence of MHE was mainly seen in patients of Ⅲa, Ⅱa and Ⅱc type. Phase Ⅰ hepatic encephalopathy mainly occurred in patients with Ⅲa, Ⅱb and Ⅳ type. Phase Ⅱ hepatic encephalopathy occurred mainly in patients with PVT-typeⅡa,Ⅱb andⅢb. Six months after TIPS, the occurrence of MHE was mainly seen in patients of type Ⅱa, Ⅱc and Ⅲb. Phase Ⅰ hepatic encephalopathy mainly occurred in patients with type Ⅱb, Ⅰ and Ⅲb. Phase Ⅱ hepatic encephalopathy occurred mainly in patients with typeⅡb,Ⅲb andⅠ. The HE condition lasted for longer time in patients withⅡb,Ⅲb andⅠtype. Conclusion The establishment of a rational anatomical classification for chronic portal vein thrombosis can effectively guide the clinical application of TIPS. The occurrence of postoperative hepatic encephalopathy is higher in patients with pure main portal vein thrombosis or superior mesenteric vein thrombosis.
出处 《介入放射学杂志》 CSCD 北大核心 2014年第8期672-678,共7页 Journal of Interventional Radiology
基金 2010年北京市科技计划项目"首都特色临床医学应用发展"基金资助项目(Z101107050210023) 首都医科大学附属北京世纪坛医院院级课题基金(2011-C18)
关键词 肝性脑病 经颈静脉肝内门体静脉分流术 门静脉血栓 覆膜支架 hepatic encephalopathy transjugular intrahepatic portasystemic shunt portal vein thrombosis covered stent
  • 相关文献

参考文献5

二级参考文献53

  • 1Yang Z, Han G, Wu Q, et al. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents:a meta- analysis. J Gastroenterol Hepatol, 2010, 25: 1718-1725.
  • 2wRiggio O, Angeloni S, Salvatori FM, et al. Incidence,natural history, and risk factors of hepatic encephalopathy after transjugular intra- hepatic portosystemic shunt with polytetrafluoroethylene-coveredstent grafts. Am J Gastroenterol, 2008, 103: 2738-2746.
  • 3Riggio O, Ridola L, Pasquale C, et al. Evidence of persistent cogni- tive impairment after resolution of overt hepatic encephalopathy. .Clin Gastroenterol Hepatol, 2010, 9: 181-183.
  • 4Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy-- definition,nomenclature, diagnosis,and quantification: final report of the working party at the llth World Congresses of Gastroenterology, Vienna,1998. Hepatology, 2002, 35: 716-721.
  • 5Nolte W, Wiltfang J, Schindler C, et al. Portosystemic hepatic en- cephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis:clinical,laboratory, psychometric,and electroencephalographic investigations. Hepatology, 1998, 28:1215- 1225.
  • 6H~iussinger D, Schliess F.Pathogenetic mechanisms of hepatic encephalopathy. Gut, 2008, 57:1156-1165.
  • 7Hassoun Z, Deschnes M, Lafortune M, et al. Relationship between pre-TIPS liver perfusion by the portal vein and the incidence of post- TIPS chronic hepatic encephalopathy. Am J Gastroenterol, 2001, 96: 1205-1209.
  • 8Mamiya Y, Kanazawa H, Kimura Y, et al. Hepatic encephalopathy after transjugnlar intrahepatic portosystemic shunt. Hepatol Res, 2004, 30: 162-168.
  • 9Stewart CA, Malinchoc M, Kim WR, et al. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl, 2007, 13: 1366-1371.
  • 10Gaba RC,Omene BO, Podczerwinski ES, et al. TIPS for treatment of variceal hemorrhage: clinical outcomes in 128 patients at a single institution over a 12-year period. J Vasc Interv Radiol, 2012,23:227-235.

共引文献38

同被引文献90

  • 1郭思恩.急性门静脉血栓的诊断及治疗进展[J].医学信息(医学与计算机应用),2014,0(23):659-659. 被引量:1
  • 2Francesca R Ponziani,Maria A Zocco,Chiara Campanale,Emanuele Rinninella,Annalisa Tortora,Luca Di Maurizio,Giuseppe Bombardieri,Raimondo De Cristofaro,Anna M De Gaetano,Raffaele Landolfi,Antonio Gasbarrini.Portal vein thrombosis:Insight into physiopathology,diagnosis,and treatment[J].World Journal of Gastroenterology,2010,16(2):143-155. 被引量:80
  • 3Mu-Xing Li,Xu-Feng Zhang,Zheng-Wen Liu,Yi Lv.Risk factors and clinical characteristics of portal vein thrombosis after splenectomy in patients with liver cirrhosis[J].Hepatobiliary & Pancreatic Diseases International,2013,12(5):512-519. 被引量:66
  • 4徐永辉,邱艺琼,李太荣,等.小承气汤配合门冬氨酸鸟氨酸治疗肝性脑病71例疗效观察.医药前沿,2013(16):67-68.
  • 5Liu F Y, Wang M Q, Fan Q S, et al. Interventional treat ment for symptomatic acute-subaeute portal and superior rues enteric venous thrombosis[J]. Word J Gastroenterol, 2009 15 (40): 5208-5034.
  • 6Irina G, Carol S, Camelia C, et al. Natural course of nonmalignant partial portal vein thrombosis in cirrhotic patients [J]. SaudiJGastroenterol, 2014, 20 (5): 288-292.
  • 7Hall T C, Garcea G, Metcalfe M, et al. Management of acute non cirrhotic non malignant portal vein thrombosis: a systematic review [J]. World Journal o[ Surgery, 2011, 35 (1): 2510-2520.
  • 8Delgado M G, Seijo S, Yepes I, et al. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis [J]. Clin Gastroenterol Hepatol, 2012, 10 ( 7 ): 776-83.
  • 9Qi X, Han G, He C, et al. Transjug~lar intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis [J]. Med Sci Monit, 2012, 18 (8): HY37-HY41.
  • 10Tsochatzis E A, Senzolo M, Germani G, et al. Systematic review: portal vein thrombosis in cirrhosis [J].Aliment PharmacolTher , 2010, 31 (3): 366 374.

引证文献11

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部